Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Capital Employed (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Return on Capital Employed for 7 consecutive years, with 0.4% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 20.0% year-over-year to 0.4%, compared with a TTM value of 0.4% through Sep 2025, down 20.0%, and an annual FY2024 reading of 0.3%, up 14.0% over the prior year.
  • Return on Capital Employed was 0.4% for Q3 2025 at Bicycle Therapeutics, down from 0.37% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.18% in Q1 2022 and bottomed at 0.4% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.3%, with a median of 0.3% recorded in 2021.
  • The sharpest move saw Return on Capital Employed rose 17bps in 2021, then dropped -20bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.19% in 2021, then crashed by -70bps to 0.32% in 2022, then dropped by -7bps to 0.35% in 2023, then soared by 33bps to 0.23% in 2024, then tumbled by -72bps to 0.4% in 2025.
  • Business Quant data shows Return on Capital Employed for BCYC at 0.4% in Q3 2025, 0.37% in Q2 2025, and 0.29% in Q1 2025.